Edibles — onset and duration

TL;DR

• Empty stomach: 30–45 min. After meal: 60–120 min.
• Peak: 2–3 h. Residual: up to 12 h.
• Sublingual (drops): 15–30 min.
• Fatty snacks roughly double bioavailability.

Why many people re-dose too early

Because nothing happens after 45 min, many take a second dose — 2 h later both potentiate into overdose. Wang 2016 flags this as the leading cause of ER visits, adults and children alike.

Time course: onset, peak and decline

The onset of action is typically 30 to 120 minutes orally, the peak after two to four hours, and the total duration extends over six to twelve hours — even longer with high doses. In contrast, when inhaled, the effect sets in within minutes and is largely over after two to four hours. This difference explains practically every unpleasant edible experience: redosing is done based on the timeline of inhalation.

The time course is also highly dependent on the state of the gastrointestinal tract. On an empty stomach, the effect comes earlier and more abruptly; with a high-fat meal, it comes later, but is stronger and more consistent. Sublingual forms such as tinctures partially bypass digestion and lie somewhere in between: 15 to 45 minutes until onset.

• Onset of action 30–120 min, peak 2–4 h, duration 6–12 h
• Empty stomach: faster and more abrupt; after a high-fat meal: later and stronger
• Sublingual as a middle ground: 15–45 min
• Residual fatigue the following day is normal with high doses

What helps in the event of an overdose

A THC overdose is unpleasant but not life-threatening — there is no documented lethal dose in humans. What helps: a quiet, familiar environment, water, no other substances, lying down and waiting. CBD can subjectively alleviate symptoms. In case of chest pain, persistent vomiting, clouded consciousness, or if children are affected: medical help. The Swiss Toxicological Information Centre is available 24/7 at 145.

Swiss classification: Under food law, cannabinoid-containing foods are classified as novel foods and require authorization from the Federal Food Safety and Veterinary Office (BLV). Under narcotics law, the total THC value remains decisive: under 1% (THC + THCA × 0.877) it is not a narcotic. Anyone working in their own kitchen for personal use operates outside of food law — if the result is sold or given away, it is immediately considered placing on the market.

The first-pass effect and the role of the liver

When consuming edibles, tetrahydrocannabinol (THC) passes through the gastrointestinal tract before entering the bloodstream. This pathway leads the active substances directly via the portal vein into the liver, where the so-called first-pass effect takes place. Here, liver enzymes metabolise a large portion of conventional delta-9-THC into the significantly more potent 11-hydroxy-THC. This metabolite crosses the blood-brain barrier much more easily and provides the more intense and psychoactive effect characteristic of edibles. Since this conversion process takes time, the onset of noticeable effects is significantly delayed compared to inhalation.

The efficiency of this conversion depends heavily on the individual's liver enzyme profile. Due to genetic factors, some people have high activity of the responsible cytochrome P450 enzymes, causing them to form the psychoactive metabolites faster and in larger quantities. This leads to a more intense effect combined with a shorter duration of action. For others, this process is slower, which further delays the onset of action and weakens the intensity. Understanding this metabolic pathway highlights why orally ingested cannabinoids exhibit completely different pharmacokinetics compared to smoked or vaporised alternatives.

• Conversion of delta-9-THC into the more potent 11-hydroxy-THC in the liver
• Delayed onset of action due to the necessary passage through the digestive tract
• Individual enzyme activity influences the intensity and duration of the effect
• Higher permeability of the blood-brain barrier for the liver metabolite

Road Traffic and Detectability under Swiss Law

In Swiss road traffic, a strict zero-tolerance policy applies with regard to cannabis, which also has far-reaching consequences for the consumption of edibles. The legal limit for driving impairment is set at a THC detection limit of 1.5 micrograms per litre of blood (1.5 µg/L). Since the degradation of orally ingested THC is unpredictable due to its delayed release from adipose tissue, the limit can still be exceeded many hours after the subjective effects have subsided. Anyone consuming edibles must be aware that, from a legal standpoint, fitness to drive is not given for an indefinite period, often well beyond twenty-four hours.

During a police check, a blood sample is ordered in cases of suspicion to determine the exact THC level. A positive result above the limit of 1.5 µg/L inevitably leads to the withdrawal of the driving licence and criminal sanctions. Since edibles are metabolised differently in the body than inhaled cannabis, inactive metabolites such as THC-carboxylic acid accumulate in the urine over days or weeks. Although these metabolites do not prove acute driving impairment, they often serve as an indicator of regular consumption for the authorities, which can trigger a review of general fitness to drive.

• Strict Swiss limit of 1.5 µg/L THC in the blood quickly leads to legal driving impairment
• Long retention time and unpredictable degradation due to delayed release from adipose tissue
• Risk of driving licence withdrawal and criminal consequences long after consumption
• Accumulation of metabolites in urine can call general fitness to drive into question

Influencing factors of individual digestion and metabolism

The speed at which an edible is digested and absorbed depends significantly on individual gastrointestinal motility. People with fast digestion often feel the effects much earlier, whereas sluggish bowel activity can delay onset by hours. The composition of the food in the stomach also plays a decisive role. Since cannabinoids are lipophilic, i.e. fat-soluble, the simultaneous ingestion of fatty foods promotes emulsification and absorption in the small intestine. This explains why an edible on a full stomach often unfolds a more even, but delayed effect.

In addition to food choices, the general health of the digestive tract also influences bioavailability. Inflammatory bowel diseases or an altered gut flora can unpredictably affect the absorption of the active ingredients. Furthermore, physical activity after consumption has an influence: exercise stimulates blood flow to the gastrointestinal tract and can accelerate the transport of the active ingredients. Conversely, stress or anxiety leads to a slowing down of digestive processes, which can paradoxically delay the onset of action and complicate dosage planning.

• Gastrointestinal motility determines the transport speed of cannabinoids
• Fat-soluble properties of THC require lipids for optimal absorption
• The health status of the gut and the gut flora alter bioavailability
• Physical activity and stress influence blood flow to the digestive tract

Risk minimisation and dosing strategies in practice

To avoid unwanted overdoses when consuming edibles, a structured approach is essential. Since the onset of effects is delayed, the most important basic rule when handling oral products is to wait at least two to three hours after the initial intake before considering a further dose. Beginners should always start with a minimal amount to safely test their body's individual sensitivity. Keeping a simple consumption diary can help to precisely document personal experiences regarding the onset and intensity of the effects.

A common mistake in practice is the uneven distribution of active ingredients in homemade products. If cannabinoids are not homogeneously distributed in the carrier substance, such as butter or oil, during baking or cooking, individual portions will contain unpredictable amounts of the active ingredient. This results in one piece of the edible showing almost no effect, while the next triggers an overdose. Careful emulsification and thorough mixing of the ingredients are therefore crucial for consistent dosing and a safe consumption experience.

• Observe a waiting time of at least two to three hours before any potential redosing
• Choose a low starting dose to test personal tolerance risk-free
• Careful homogenisation of the carrier fats prevents uneven concentrations of active ingredients
• Use a consumption diary to document meals, dose, and onset of effects

FAQ